NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year-over-year uptick in fiscal first quarter revenues driven by balanced contributions from its key operating segments.

For the three months ended Dec. 31, the Cincinnati-based molecular diagnostics and life science research tools firm brought in revenue of $48 million compared to $44.8 million in the same quarter last year and beating the consensus analysts' estimate of $46.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.